Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty

• Status: Completed
• Trial end date: 2018-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rothman Institute Orthopaedics
• Treatments: Analgesics, Opioid

Criteria

Inclusion Criteria:

• Patients undergoing unilateral, primary cementless THA with underlying diagnosis of osteoarthritis.

• ASA I - III

• Spinal anesthesia

• Male and Female over 18 who are willing and able to provide informed consent

Exclusion Criteria:

• Opioid use within 3 months prior to surgery

• General anesthesia

• Non-english speaking

• ASA IV or greater

• Allergy/contraindications to protocol medications

• Renal insufficiency with Cr > 2.0 or hepatic failure

• Sensory/motor disorder involving the operative limb

• Planned or unplanned discharge to rehab

• Length of stay >3 days

• Revision or conversion THA

• Cigarette smokers